How to Help Your Patients Find Climara Pro in Stock: A Provider's Guide

Your patients can't find Climara Pro — here's how you can help

When patients call your office saying they can't fill their Climara Pro prescription, it's more than an inconvenience. For women managing moderate to severe vasomotor symptoms or relying on HRT for osteoporosis prevention, a gap in therapy can mean a rapid return of hot flashes, night sweats, sleep disruption, and bone loss risk.

As a prescriber, you're in a unique position to help. This guide covers practical steps you can take to help patients locate Climara Pro, manage supply disruptions, and transition to alternatives when necessary.

Current Climara Pro availability

Climara Pro (estradiol 0.045 mg/levonorgestrel 0.015 mg per day transdermal patch) has been subject to intermittent supply constraints since late 2023. Key factors include:

• Sole manufacturer: Bayer is the only manufacturer. No generic exists.
• Increased demand: More providers and patients are choosing transdermal HRT, outpacing supply.
• Supply chain issues: HRT patch manufacturing has been affected by adhesive sourcing and quality control challenges across the industry.
• Market shifts: Discontinuation of the Climara (estradiol-only) patch in some markets has pushed more patients toward combination products.

For a detailed timeline, see: Climara Pro shortage: what providers need to know in 2026.

Why patients can't find it

Even when Bayer is producing Climara Pro, individual pharmacies may not have it for several reasons:

• Pharmacy ordering patterns: Many pharmacies only order Climara Pro on demand (when a prescription comes in), rather than keeping it in regular stock. This creates a delay of 2–5 business days.
• Wholesaler allocation: During tight supply periods, wholesalers may limit quantities per pharmacy, prioritizing pharmacies with higher historical ordering volumes.
• Regional variation: Supply distribution isn't uniform. Some regions have better access than others based on wholesaler distribution centers and pharmacy density.
• Cost barrier: At $250–$365/month cash price, some pharmacies are reluctant to stock a brand-name product that may sit on the shelf if not dispensed quickly.

What providers can do: 5 practical steps

Step 1: Use Medfinder to locate pharmacy stock

Medfinder for Providers lets you or your staff check real-time pharmacy availability for Climara Pro by location. Instead of asking patients to call pharmacy after pharmacy, you can direct them to a specific location that currently has stock. This is the single most efficient action you can take.

Step 2: Send prescriptions to pharmacies with confirmed stock

Once you've identified a pharmacy with Climara Pro in stock using Medfinder, send the prescription directly to that pharmacy. This avoids the common scenario where a patient arrives at their usual pharmacy only to find it's unavailable, then has to request a transfer — which adds days to the process.

Step 3: Consider independent and specialty pharmacies

Independent pharmacies often have different wholesaler relationships than chain pharmacies and may have better access to specialty products like Climara Pro. Women's health specialty pharmacies are particularly likely to maintain regular stock. Build relationships with 2–3 independent pharmacies in your area that reliably carry HRT products.

Step 4: Prescribe 90-day supplies when possible

If the patient's insurance allows it, prescribing a 90-day supply (12 patches) — especially through mail-order pharmacy — can reduce the frequency of stock-out encounters. Mail-order pharmacies typically have access to larger wholesaler inventories and are less affected by local supply variability.

Step 5: Document a backup plan in the chart

For every patient on Climara Pro, consider documenting an alternative medication in the chart — including the specific drug, dose, and any relevant counseling notes. This way, if Climara Pro becomes unavailable, you or a colleague can quickly switch the patient without a separate office visit. Common alternatives include:

• CombiPatch (estradiol/norethindrone acetate) — twice-weekly patch
• Activella (estradiol/norethindrone acetate) — daily oral; generic available
• Prempro (conjugated estrogens/MPA) — daily oral; generic available
• Bijuva (estradiol/progesterone) — daily oral; bioidentical

Alternatives in detail

When switching patients off Climara Pro, here's what to consider for each alternative:

CombiPatch

Most similar delivery method. Uses norethindrone acetate instead of levonorgestrel. Applied twice weekly. Brand-name only ($250–$400/month). Best for patients who strongly prefer transdermal delivery and are willing to change patches more frequently.

Activella (generic available)

Oral combination of estradiol and norethindrone acetate. Generic versions available at $30–$80/month. Most accessible and affordable alternative. Consider for patients without strong contraindications to oral estrogen (e.g., elevated VTE risk, hepatic concerns).

Prempro (generic available)

Oral combination using conjugated estrogens and MPA. Generic versions at $30–$60/month. Extensive long-term safety data from WHI and other studies. Uses non-bioidentical hormones, which some patients may prefer to avoid.

Bijuva

The only FDA-approved combination of bioidentical estradiol and progesterone. Brand-name only at $200–$300/month. May appeal to patients who specifically want bioidentical hormones in a single product.

For a patient-facing comparison: Alternatives to Climara Pro.

Workflow tips for your practice

• Flag Climara Pro patients in your EHR: Create a list or tag for patients currently on Climara Pro so you can proactively reach out if supply changes.
• Delegate stock checking to staff: Train medical assistants or pharmacy liaisons to use Medfinder for stock checks before sending prescriptions.
• Pre-authorize alternatives: If your practice uses prior authorization workflows, consider submitting PAs for backup medications in advance so there's no delay if a switch is needed.
• Share patient resources: Direct patients to these guides so they can take proactive steps on their own:
• How to find Climara Pro in stock near you
• How to save money on Climara Pro
• Climara Pro shortage update for patients

Final thoughts

Drug shortages are a systems problem, but the impact is felt one patient at a time. By incorporating stock-checking tools like Medfinder into your workflow, maintaining backup prescribing plans, and communicating proactively with patients, you can minimize treatment gaps and reduce the frustration that comes with supply disruptions.

Your patients are already stressed about their symptoms. Don't let pharmacy availability add to that stress.